Background Image
Previous Page  150 / 156 Next Page
Information
Show Menu
Previous Page 150 / 156 Next Page
Page Background

148

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

305

Sniezek PJ, Brodland DG, Zitelli JA. A randomized controlled trial comparing acetamino-

phen, acetaminophen and ibuprofen, and acetaminophen and codeine for postoperative

pain relief after Mohs surgery and cutaneous reconstruction. Dermatol Surg 2011; 37(7):

1007-1013.

306

Stamenkovic D, Geric V, Djordjevic M, Raskovic J, Slavkovic Z, Randjelovic T, Karanikolas

M. Subarachnoid morphine, bupivacaine and fentanyl as part of combined spinal-epidu-

ral analgesia for low anterior resection. A prospective, randomised, double-blind clinical

trial. Anaesth Intensive Care 2009; 37(4): 552-560.

307

Stiehl M. [Controlled release oxycodone--a new option in the treatment of severe and

very severe pain. Review of studies on neuropathic, physical activity-related and postope-

rative pain]. MMW Fortschr Med 2004; 146 Suppl 2: 61-69.

308

Stränger J, Pförtner R, Mohr C. Bisphosphonat – assoziierte Kieferosteonekrose. best

practice onkologie, 2008; (3), 42 – 51.

309

Strassels SA, Blough DK, Hazlet TK, Veenstra DL, Sullivan SD. Pain, demographics, and

clinical characteristics in persons who received hospice care in the United States. J Pain

Symptom Manage 2006; 32(6): 519-531.

310

Suzuki T, Morishita M, Ito E, Matsuura M, Tanaka R, Saito T. Analgesic efficacy of

controlled-release oxycodone in patients with uterine or ovarian cancer. Am J Ther 2008;

15(1): 31-35.

311

Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, DuPen S, Stillman M, Fredrick-

son M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland CS, DuPen A.

Patient training in cancer pain management using integrated print and video materials: a

multisite randomized controlled trial. Pain 2008; 135(1-2): 175-186.

312

Taguchi H, Oishi K, Sakamoto S, Shingu K. Intrathecal betamethasone for cancer pain in

the lower half of the body: a study of its analgesic efficacy and safety. Br J Anaesth 2007;

98(3): 385-389.

313

Takahashi H, Shimoyama N. A prospective open-label trial of gabapentin as an adjuvant

analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin

Oncol 2010; 15(1): 46-51.

314

Talamo G, Liao J, Bayerl MG, Claxton DF, Zangari M. Oral administration of analgesia

and anxiolysis for pain associated with bone marrow biopsy. Support Care Cancer 2010;

18(3): 301-305.

315

Tasmacioglu B, Aydinli I, Keskinbora K, Pekel AF, Salihoglu T, Sonsuz A. Effect of intrave-

nous administration of paracetamol on morphine consumption in cancer pain control.

Support Care Cancer 2009; 17(12): 1475-1481.

316

Tassinari D, Sartori S, Tamburini E, Scarpi E, Raffaeli W, Tombesi P, Maltoni M. Adverse

effects of transdermal opiates treating moderate-severe cancer pain in comparison to

long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat

Med 2008; 11(3): 492-501.

317

Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M. Trans-

dermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of

randomized clinical trials. J Palliat Care 2009; 25(3): 172-180.

Literaturverzeichnis